What is European Biotech Acquisition Corp. (EBAC) stock price today?

European Biotech Acquisition Corp. (EBAC) is currently trading at $11.19, down 4.44% today.

What is EBAC P/E ratio?

European Biotech Acquisition Corp.'s P/E ratio is 41.44. This is above the market average, reflecting high growth expectations.

What is EBAC return on equity (ROE)?

European Biotech Acquisition Corp.'s return on equity (ROE) is 2.90%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is European Biotech Acquisition Corp.'s market cap?

European Biotech Acquisition Corp. has a market capitalization of $183.50M.

NASDAQ · Shell Companies

European Biotech Acquisition Corp. (EBAC) Stock

$11.19 -4.44% NASDAQ: EBAC Financial Services

European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations.

Valuation

Metric	Value
Price	$11.19
Market Cap	$183.50M
P/E Ratio	41.44
P/B Ratio	1.18
P/S Ratio	0.00
EPS (TTM)	$0.27
52-Week High	$14.10
52-Week Low	$9.28
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.90%
ROA	2.70%
ROCE	-2.19%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	0.45

Annual Financials (USD)

Metric	2021	2022
Revenue	$0	$0
Operating Profit	$-1.0M	$-3.0M
Net Profit	$1.0M	$4.0M
EPS	$0.11	$0.27
Op Margin	—	—

Balance Sheet (USD)

Metric	2021	2022
Total Assets	$128.0M	$130.0M
Total Liabilities	$8.0M	$9.0M
Cash	$1.0M	$0
Borrowings	$0	$0

Latest News

Community Bank (CBU) Q2 Earnings: What To Expect StockStory · Jul 27, 2026 Warren Buffett's Favorite Stock Market Indicator Is Sounding the Alarm. History Suggests Investors Are "Playing With Fire." Motley Fool · Jul 27, 2026 Merchants Bancorp (MBIN) Reports Q2: Everything You Need To Know Ahead Of Earnings StockStory · Jul 27, 2026 tonies introduces Toniebox Lite: growing the globally loved audio ecosystem for children PR Newswire · Jul 27, 2026 Alonso says 'great signing' Rogers can rejuvenate Chelsea AFP · Jul 27, 2026

Cash Flow (USD)

Metric	2021	2022
Operating Cash Flow	$-1.0M	$-1.0M
Investing Cash Flow	$-128.0M	$0
Financing Cash Flow	$129.0M	$0
Net Cash Flow	$1.0M	$-1.0M
Free Cash Flow	$-1.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.79
EV / EBITDA	0.00
FCF Yield	-0.28%
Quick Ratio	0.45
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APCAAP Acquisition Corp.	$11.45	-0.04%	67.35	$178.79M	0.00%
BTWNBridgetown Holdings Limited	$6.15	-4.06%	—	$184.30M	0.00%
CONXDirexion Daily COIN Bull 2X ETF	$6.43	-10.82%	1.79	$1.24M	2.02%
GSQBG Squared Ascend II Inc.	$10.44	+0.10%	13.38	$187.59M	0.00%
PRBMParabellum Acquisition Corp.	$9.95	-0.50%	29.26	$178.79M	0.00%

About European Biotech Acquisition Corp.

European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.

European Biotech Acquisition Corp. is headquartered in NL.

European Biotech Acquisition Corp. (EBAC) stock trades at $11.19 with a market capitalization of $183.50M. The stock is valued at a price-to-earnings (P/E) ratio of 41.44, price-to-book of 1.18, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.28 and $14.10, and currently trades 20.6% below its 52-week high.

On profitability, European Biotech Acquisition Corp. generates a return on equity (ROE) of 2.90%, return on capital employed of -2.19%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.lspvc.com/ebac